Dergiler / BEYOGLU EYE JOURNAL / 2021 / Cilt: 6 - Sayı: 1

The Effect of Long-Term Usage of Single-Agent Antiglaucomatous Drops with Different Preservatives on Cornea Biomechanics

Sayfa
24–30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Variation in CH in patients using antiglaucomatous drops over a long period is important in both the progression and follow-up of the disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study examined the effect of antiglaucomatous drops with different preservatives on corneal biomechanics using the ocular response analyzer (ORA) (Reichert Technologies, Inc., Depew, NY, USA).Methods: Patients using antiglaucomatous medical treatment containing a single agent combined with a preservative for at least 1 year who underwent a control examination between January and December 2017 at a glaucoma unit were included in this retrospective study.
📊
Temel Bulgular & Veri:The patients were divided into 5 groups according to the antiglaucomatous agent and preservative ingredients.
💡
Sonuç & Katkı:Variation in CH in patients using antiglaucomatous drops over a long period is important in both the progression and follow-up of the disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This study examined the effect of antiglaucomatous drops with different preservatives on corneal biomechanics using the ocular response analyzer (ORA) (Reichert Technologies, Inc., Depew, NY, USA).Methods: Patients using antiglaucomatous medical treatment containing a single agent combined with a preservative for at least 1 year who underwent a control examination between January and December 2017 at a glaucoma unit were included in this retrospective study. The patients were divided into 5 groups according to the antiglaucomatous agent and preservative ingredients. Measurements were taken with the ORA and compared with a control group.Results: A total of 83 eyes treated eyes were included and analyzed. Thirty-three eyes of 33 patients were treated with latanoprost+benzalkonium chloride (BAC), 17 eyes of 17 patients were treated with travoprost+polyquad, 7 eyes of 7 patients were treated with bimatoprost+BAC, 18 eyes of 18 patients were treated with brimonidine+purite, 8 eyes of 8 patients were treated with brimonidine+BAC. A control group of 23 eyes of 23 healthy patients was also assessed for comparison. A significant decrease in corneal hysteresis (CH) and corneal resistance factor (CRF) was seen in the patients using bimatoprost+BAC and brimonidine+BAC when compared with the control group. Evaluation of the bimatoprost+BAC group and the latanoprost+BAC group revealed that the CH and the CRF was significantly lower in the group using bimatoprost+BAC (p<0.01).Conclusion: It has been reported that CH is a more important prognostic marker than central corneal thickness in glaucoma patients. Loss of visual field progresses faster in eyes with a low CH. Both preservatives and the active antiglaucomatousagents in medications can affect CH. Variation in CH in patients using antiglaucomatous drops over a long period is important in both the progression and follow-up of the disease.

🔖

Bu Makaleye Atıf Yap

AYDEMİR, G. A., DEMİROK, G., EKSİOĞLU, Ü., YAKIN, M., ÖRNEK, F. (2021). The Effect of Long-Term Usage of Single-Agent Antiglaucomatous Drops with Different Preservatives on Cornea Biomechanics. BEYOGLU EYE JOURNAL, Cilt: 6 - Sayı: 1, 24–30. https://ajindex.com/articles/353064

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 1994;112:1437–45
  2. Yalvaç IS, Gedikoğlu G, Karagöz Y, Akgün U, Nurözler A, Koç F, et al. Effects of antiglaucoma drugs on ocular surface. Acta Ophthalmol Scand 1995;73:246–8
  3. Arici MK, Arici DS, Topalkara A, Güler C. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exp Ophthalmol 2000;28:113–7
  4. Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999;106:556–63. 5. van Beek LM, de Keizer RJ, Polak BC, Elzenaar PR, van Haeringen NJ, Kijlstra A. Incidence of ocular side effects of topical beta blockers in the Netherlands. Br J Ophthalmol 2000;84:856–9
  5. Baudouin C, Denoyer A, Desbenoit N, Hamm G, Grise A. In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2012;110:40–63
  6. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 1989;96:327–35
  7. Luce DA. Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg 2005;31:156–62
  8. Doğanay S, Çankaya C. Glokom ilaçlarının gelişimi ve ilaç tedavi prensipleri. Glokom-Katarakt Dergisi 2010;5:179–85
  9. Brown KE, Congdon NG. Corneal structure and biomechanics: impact on the diagnosis and management of glaucoma. Curr Opin Ophthalmol 2006;17:338–43
  10. Iordanidou V, Hamard P, Gendron G, Labbe A, Raphael M, Baudouin C. Modifications in corneal biomechanics and intraocularpressure after deep sclerectomy. J Glaucoma 2010;19:252–6
  11. Sun L, Shen M, Wang J, Fang A, Xu A, Fang H, et al. Recovery of corneal hysteresis after reduction of intraocular pressure in chronic primary angleclosure glaucoma. Am J Ophthalmol 2009;147:1061–6, 1066.e1–2
  12. Susanna CN, Diniz-Filho A, Daga FB, Susanna BN, Zhu F, Ogata NG, et al. A prospective longitudinal study to investigate cor neal hysteresis as a risk factor for predicting development of glaucoma. Am J Ophthalmol 2018;187:148–52
  13. Medeiros FA, Meira-Freitas D, Lisboa R, Kuang TM, Zangwill LM, Weinreb RN. Corneal hysteresis as a risk